All Stories

  1. Red Yeast Rice (RYR) supplementation in patients treated with second-generation antipsychotics
  2. Inside–out: the role of anger experience and expression in the development of postpartum mood disorders
  3. Bergamot Polyphenolic Fraction Supplementation Improves Cognitive Functioning in Schizophrenia
  4. Academic stress disrupts cortical plasticity in graduate students
  5. Abnormal illness behavior and Internet addiction severity: The role of disease conviction, irritability, and alexithymia
  6. Metabolic outcomes of bergamot polyphenolic fraction administration in patients treated with second-generation antipsychotics: a pilot study
  7. Anger, Smoking Behavior, and the Mediator Effects of Gender: An Investigation of Heavy and Moderate Smokers
  8. Psychopharmacotherapy in Pregnancy and Breastfeeding
  9. The Role of Levomilnacipran in the Management of Major Depressive Disorder: A Comprehensive Review
  10. Personality traits and emotional patterns in irritable bowel syndrome
  11. Self-worth and psychological adjustment of obese children: An analysis through the Draw-A-Person
  12. Acetyl-L-Carnitine Augmentation of Clozapine in Partial-Responder Schizophrenia
  13. Effect of Ziprasidone Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder
  14. Generic Olanzapine Substitution in Patients With Schizophrenia
  15. The RS685012 Polymorphism of ACCN2, the Human Ortholog of Murine Acid-Sensing Ion Channel (ASIC1) Gene, is Highly Represented in Patients with Panic Disorder
  16. Analysis of psychopathological comorbidity behind the common symptoms and signs of endometriosis
  17. Extrasensory Perception Experiences and Childhood Trauma
  18. Rare and very rare adverse effects of clozapine
  19. Efficacy and Safety of Sertindole in Schizophrenia
  20. Association of the COMT synonymous polymorphism Leu136Leu and missense variant Val158Met with mood disorders
  21. Anger in women treated with assisted reproductive technology (ART): effects on mother and newborn
  22. Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine
  23. Reboxetine Adjuvant Therapy in Patients With Schizophrenia Showing a Suboptimal Response to Clozapine
  24. Sertindole in schizophrenia: efficacy and safety issues
  25. Augmentation of Clozapine With Agomelatine in Partial-Responder Schizophrenia
  26. Dental anxiety in relation to aggressive characteristics of patients
  27. Obsessive-compulsive disorder: A “sensory-motor” problem?
  28. Prevalence of Internet Addiction in a Sample of Southern Italian High School Students
  29. Aripiprazole Plus Topiramate in Opioid-Dependent Patients With Schizoaffective Disorder: An 8-Week, Open-Label, Uncontrolled, Preliminary Study
  30. Executive functions and basic symptoms in adolescent antisocial behavior: A cross-sectional study on an Italian sample of late-onset offenders
  31. Augmentation of Clozapine With Ziprasidone in Refractory Schizophrenia
  32. Unraveling Exercise Addiction: The Role of Narcissism and Self-Esteem
  33. Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome
  34. The Relationship between Alexithymia, Anxiety, Depression, and Internet Addiction Severity in a Sample of Italian High School Students
  35. Agomelatine in the Treatment of Fibromyalgia
  36. Dental anxiety, psychiatry and dental treatment: How are they linked?
  37. Drugs and Sexual Behavior
  38. Alexithymia, Negative Emotions, and Sexual Behavior in Heterosexual University Students from Italy
  39. Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder: a double-blind, placebo-controlled study
  40. Clinically relevant drug interactions in anxiety disorders
  41. Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia
  42. Effect of Aripiprazole Augmentation of Serotonin Reuptake Inhibitors or Clomipramine in Treatment-Resistant Obsessive-Compulsive Disorder
  43. Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study
  44. The Relationship between Anger and Heterosexual Behavior. An Investigation in a Nonclinical Sample of Urban Italian Undergraduates
  45. Effect of Adjunctive Duloxetine on the Plasma Concentrations of Clozapine, Olanzapine, and Risperidone in Patients With Psychotic Disorders
  46. Emerging treatments in the management of schizophrenia – focus on sertindole
  47. Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study
  48. Morphometrical and morphological analysis of lateral ventricles in schizophrenia patients versus healthy controls
  49. Depression, Anxiety and Anger in Subtypes of Irritable Bowel Syndrome Patients
  50. Effect of Valproate on Olanzapine Plasma Concentrations in Patients With Bipolar or Schizoaffective Disorder
  51. Mental disorders and request for psychiatric intervention in an Italian local jail
  52. Gender Role Identity in a Sample of Italian Male Homosexuals
  53. Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model
  54. Therapeutic Drug Monitoring of Quetiapine: Effect of Coadministration with Antiepileptic Drugs in Patients with Psychiatric Disorders
  55. Defense mechanisms in a sample of non-psychiatric obese subjects
  56. The role of defense mechanisms in the modulation of anger experience and expression: Gender differences and influence on self-report measures
  57. The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: A double-blind, placebo-controlled study
  58. Temperament and Character Dimensions in Opiate Addicts: Comparing Subjects Who Completed Inpatient Treatment in Therapeutic Communities vs. Incompleters
  59. Effect of Adjunctive Lamotrigine Treatment on the Plasma Concentrations of Clozapine, Risperidone and Olanzapine in Patients With Schizophrenia or Bipolar Disorder
  60. Association between Burnout and Anger in Oncology versus Ophthalmology Health Care Professionals
  61. Anger and ego-defence mechanisms in non-psychiatric patients with irritable bowel syndrome
  62. Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophrenia
  63. Plasma Concentrations of Risperidone and Olanzapine during Coadministration with Oxcarbazepine
  64. Urinary incontinence in schizophrenic patients treated with atypical antipsychotics: urodynamic findings and therapeutic perspectives
  65. Panic-agoraphobic spectrum in obese binge eaters
  66. The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study
  67. Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia
  68. Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder
  69. Estrogen receptor expression and depressive mood disorders in untreated breast cancer patients
  70. Prevalence of Depressive Mood Disorders in Breast Cancer Patients of Southern Italy